Anti-HER2 Human Monoclonal Antibody

Supplier: BioVision
BIOVA1046-100EA 491 EUR
Anti-HER2 Human Monoclonal Antibody
Trastuzumab is a recombinant humanized monoclonal immunoglobulin G1 kappa antibody that binds with high affinity and specificity to the extracellular domain of the HER2 receptor. A growth factor receptor gene, human epidermal growth factor receptor (HER2), is amplified in 25 to 30 % of breast cancers and in these cases the encoded protein is present in abnormally high levels in the malignant cells. Trastuzumab is used to treat adjuvant and metastatic breast cancer as well as metastatic gastric cancer.

Type: Primary
Antigen: HER2
Clonality: Monoclonal
Conjugation: Unconjugated
Host: Human
Isotype: IgG1
Reactivity: Human
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR